Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of Labor

Sponsor
Municipal Hospital Vila Nova Cachoeirinha (Other)
Overall Status
Completed
CT.gov ID
NCT01140971
Collaborator
(none)
180
1
2
36
5

Study Details

Study Description

Brief Summary

PURPOSE: The purpose of this study is to determine the effectiveness of balloon dilatation (Foley) with vaginal misoprostol for cervical ripening and induction of labor.

METHOD: a randomized clinical assay has been performed with 160 women with indication of induction of labor, randomly divided in two groups, 80 for Foley catheter and 80 for misoprostol.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

The cesarean delivery rate has risen dramatically in almost all world. Brazil shows the highest rate in the world so we need urgently efforts to reduce this fact. Several studies have shown that maternal morbidity and mortality rates are higher in cesarean deliveries. On the other hand an abdominal delivery cost much more than a vaginal delivery.

A clinical trial to assess the performance of two simple and sheep methods can provide evidence based on local experience. Our results alow us to recommend both methods for clinical practice with a good possibility to reduce cesarean rates and without adverse events.

Study Design

Study Type:
Interventional
Actual Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
TRANSCERVICAL FOLEY CATHETER (FOLEY) Versus INTRAVAGINAL MISOPROSTOL FOR CERVICAL RIPENING AND INDUCTION OF LABOR: A RANDOMIZED CLINICAL TRIAL.
Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Mar 1, 2008
Actual Study Completion Date :
Jan 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Misoprostol

Use 25 micrograms vaginal every 6 hours (max dosis 200 micrograms in 48 hours)

Drug: Misoprostol
Vaginal application of 25 micrograms every 6 hours until cervical ripening reach Bishop 6 or more
Other Names:
  • Prostokos 25 micrograms
  • Active Comparator: Foley

    Foley catheter number 14 or 16 was installed intracervical for no more than 48 hours.

    Device: Foley
    After Foley introduction, every 6 hours vaginal exam was performed. The cases on Bishop score increase or occurred spontaneous exit of catheter or spontaneous labour had been initiated are considered success.The failure was adopted if after48 hours occurred no cervical modifications.

    Outcome Measures

    Primary Outcome Measures

    1. Cervical ripening [48 hous after start the method]

      Foley Group: catheter stay no more that 48 hours. Every 6 hours vaginal exam was performed. The cases on Bishop score increase or occurred spontaneous exit of catheter or spontaneous labour had been initiated are considered success.The failure was adopted if after48 hours occurred no cervical modifications. Misoprostol group: was introduced 25 microgram every 6 hour (max 200microg)if cervical conditions were unchanged. In the case of cervical evolution or start of labour the method was considered success.The failure was adopted if after 48 there was no cervical modifications.

    Secondary Outcome Measures

    1. Cesarean [The action of methods were assessed for 48 hours after start.]

      After 48 hours if there was no cervical ripening or espontaneous labor the case was classified as failure of method and a cesarean was performed

    2. Need of oxytocin [48 hours after start method]

      In cases on the cervical ripening had occurred but the spontaneous labor not start.

    3. need of neonatal intensive care [7 first days after birth]

      The condition of babies at birth and needs of intensive care as mechanic ventilation or others interventions.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 40 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Gestational age from 37 weeks,

    • feto unic, alive and cephalic,

    • Bishop index equal or lesser than four.

    Exclusion Criteria:
    • uterine scar,

    • premature rupture of the membranes,

    • fetal weight bigger than 4000 g,

    • previous placenta,

    • conditions that imposed the immediate ending of the gestation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 MHVNCachoeirinha São Paulo Brazil 02720-200

    Sponsors and Collaborators

    • Municipal Hospital Vila Nova Cachoeirinha

    Investigators

    • Principal Investigator: Nelson Sass, pHD, Maternidade Escola de Vila Nova Cachoeirinha

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01140971
    Other Study ID Numbers:
    • MHVNCachoeirinha
    First Posted:
    Jun 10, 2010
    Last Update Posted:
    Jun 10, 2010
    Last Verified:
    Sep 1, 2009

    Study Results

    No Results Posted as of Jun 10, 2010